Danaher Co. (NYSE:DHR) Shares Sold by Hunter Associates Investment Management LLC

Hunter Associates Investment Management LLC lowered its position in shares of Danaher Co. (NYSE:DHR) by 3.0% in the fourth quarter, HoldingsChannel.com reports. The firm owned 1,470 shares of the conglomerate’s stock after selling 46 shares during the quarter. Hunter Associates Investment Management LLC’s holdings in Danaher were worth $338,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also recently modified their holdings of the company. Boomfish Wealth Group LLC boosted its stake in Danaher by 14.3% in the fourth quarter. Boomfish Wealth Group LLC now owns 3,743 shares of the conglomerate’s stock valued at $859,000 after acquiring an additional 468 shares in the last quarter. Norris Perne & French LLP MI boosted its stake in Danaher by 58.8% in the fourth quarter. Norris Perne & French LLP MI now owns 130,356 shares of the conglomerate’s stock valued at $29,923,000 after acquiring an additional 48,261 shares in the last quarter. Strategic Wealth Investment Group LLC boosted its stake in Danaher by 11.5% in the fourth quarter. Strategic Wealth Investment Group LLC now owns 41,176 shares of the conglomerate’s stock valued at $9,452,000 after acquiring an additional 4,263 shares in the last quarter. Gilbert & Cook Inc. boosted its stake in Danaher by 2.5% in the fourth quarter. Gilbert & Cook Inc. now owns 1,749 shares of the conglomerate’s stock valued at $401,000 after acquiring an additional 42 shares in the last quarter. Finally, Crews Bank & Trust acquired a new position in Danaher in the fourth quarter valued at $551,000. Institutional investors and hedge funds own 79.05% of the company’s stock.

Insider Activity

In related news, SVP Brian W. Ellis sold 5,700 shares of the firm’s stock in a transaction that occurred on Thursday, January 30th. The shares were sold at an average price of $224.13, for a total transaction of $1,277,541.00. Following the sale, the senior vice president now owns 20,230 shares in the company, valued at approximately $4,534,149.90. This trade represents a 21.98 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Company insiders own 11.10% of the company’s stock.

Wall Street Analysts Forecast Growth

DHR has been the subject of several research analyst reports. Bank of America upgraded shares of Danaher from a “neutral” rating to a “buy” rating and set a $290.00 price objective for the company in a research note on Friday, December 13th. Robert W. Baird reduced their target price on shares of Danaher from $277.00 to $268.00 and set an “overweight” rating for the company in a report on Tuesday. Royal Bank of Canada reaffirmed an “outperform” rating and issued a $277.00 target price (down from $299.00) on shares of Danaher in a report on Thursday. StockNews.com cut shares of Danaher from a “buy” rating to a “hold” rating in a report on Saturday, December 14th. Finally, Citigroup reduced their target price on shares of Danaher from $285.00 to $265.00 and set a “buy” rating for the company in a report on Thursday. Six analysts have rated the stock with a hold rating and sixteen have issued a buy rating to the company’s stock. According to MarketBeat, the company has an average rating of “Moderate Buy” and an average target price of $278.00.

Danaher Trading Down 0.2 %

Shares of Danaher stock opened at $222.56 on Friday. The company has a 50-day moving average of $235.66 and a two-hundred day moving average of $253.24. The stock has a market cap of $160.75 billion, a PE ratio of 42.15, a price-to-earnings-growth ratio of 4.22 and a beta of 0.83. Danaher Co. has a 12-month low of $221.34 and a 12-month high of $281.70. The company has a current ratio of 1.37, a quick ratio of 1.01 and a debt-to-equity ratio of 0.32.

Danaher (NYSE:DHR) last released its quarterly earnings results on Wednesday, January 29th. The conglomerate reported $2.14 EPS for the quarter, meeting the consensus estimate of $2.14. Danaher had a net margin of 16.33% and a return on equity of 10.72%. During the same period last year, the firm earned $2.09 EPS. On average, research analysts anticipate that Danaher Co. will post 8.15 EPS for the current fiscal year.

Danaher Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, January 31st. Stockholders of record on Friday, December 27th were given a $0.27 dividend. The ex-dividend date of this dividend was Friday, December 27th. This represents a $1.08 annualized dividend and a dividend yield of 0.49%. Danaher’s dividend payout ratio is presently 20.45%.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.